IMV (TSE:IMV) Stock Price Down 3.7%

Imv Inc (TSE:IMV)’s share price dropped 3.7% during mid-day trading on Wednesday . The company traded as low as C$3.60 and last traded at C$3.65, approximately 23,210 shares changed hands during mid-day trading. A decline of 43% from the average daily volume of 40,660 shares. The stock had previously closed at C$3.79.

The stock’s 50-day moving average price is C$3.73 and its 200-day moving average price is C$4.26. The company has a market cap of $182.20 million and a P/E ratio of -6.96. The company has a debt-to-equity ratio of 44.63, a current ratio of 5.74 and a quick ratio of 5.01.

IMV (TSE:IMV) last posted its quarterly earnings data on Thursday, August 8th. The company reported C($0.10) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of C($0.13) by C$0.03. The firm had revenue of C$0.19 million for the quarter, compared to the consensus estimate of C$0.10 million. As a group, analysts expect that Imv Inc will post -0.28 EPS for the current fiscal year.

About IMV (TSE:IMV)

IMV Inc, a clinical-stage immuno-oncology company, together with its subsidiaries, develops products based on its platform and products with a primary focus on T cell activating therapies for cancer. The company's DPX drug development platform provides a patented delivery formulation that enables controlled and prolonged exposure of antigens to the immune system.

Recommended Story: Moving Average Convergence Divergence (MACD)

Receive News & Ratings for IMV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMV and related companies with MarketBeat.com's FREE daily email newsletter.